Adaptix receives FDA 510(K) clearance

Summary by AI BETAClose X

Avingtrans plc announced that its subsidiary, Adaptix Limited, has received 510(k) clearance from the U.S. Food and Drug Administration for its Adaptix Ortho350, a 3D Digital Tomosynthesis imaging system designed for point-of-care orthopaedic use. This clearance allows Adaptix to enter the substantial U.S. human healthcare imaging market, building on its prior commercial success in veterinary and industrial sectors with similar technology. The Ortho350 offers fast, lower-cost, 3D X-ray imaging with a fraction of the radiation dose of traditional CT systems, aiming to improve diagnostic accuracy and patient outcomes.

Disclaimer*

Companies

Avingtrans (AVG)
UK 100

Latest directors dealings